Claire Mathiot

13.8k total citations
116 papers, 4.9k citations indexed

About

Claire Mathiot is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Claire Mathiot has authored 116 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Oncology, 47 papers in Hematology and 39 papers in Molecular Biology. Recurrent topics in Claire Mathiot's work include Multiple Myeloma Research and Treatments (41 papers), Monoclonal and Polyclonal Antibodies Research (18 papers) and Cancer Cells and Metastasis (17 papers). Claire Mathiot is often cited by papers focused on Multiple Myeloma Research and Treatments (41 papers), Monoclonal and Polyclonal Antibodies Research (18 papers) and Cancer Cells and Metastasis (17 papers). Claire Mathiot collaborates with scholars based in France, Belgium and United States. Claire Mathiot's co-authors include François‐Clément Bidard, Jean‐Yves Pierga, Thierry Façon, Philippe Moreau, Michel Attal, Hervé Avet‐Loiseau, Gérald Marit, Wolf H. Fridman, Suzette Delaloge and Étienne Brain and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Claire Mathiot

112 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claire Mathiot France	35	2.7k	2.3k	2.1k	1.0k	696	116	4.9k
Josef Vormoor Germany	35	3.5k 1.3×	3.2k 1.4×	2.7k 1.3×	1.2k 1.2×	1.5k 2.1×	117	7.8k
John P. Chute United States	38	1.5k 0.5×	2.0k 0.9×	1.9k 0.9×	624 0.6×	1.0k 1.5×	135	5.0k
Guenther Gastl Austria	38	2.2k 0.8×	1.6k 0.7×	589 0.3×	669 0.6×	1.4k 2.0×	110	4.9k
James A. Zwiebel United States	44	2.5k 0.9×	4.7k 2.1×	801 0.4×	933 0.9×	484 0.7×	140	7.3k
Pier Francesco Ferrucci Italy	37	3.7k 1.4×	2.9k 1.3×	1.2k 0.6×	409 0.4×	1.7k 2.4×	141	6.2k
David Avigan United States	42	2.9k 1.1×	3.0k 1.3×	2.6k 1.2×	702 0.7×	3.7k 5.3×	208	7.5k
Cyrus V. Hedvat United States	35	1.7k 0.6×	2.6k 1.1×	1.3k 0.6×	1.2k 1.1×	861 1.2×	76	5.4k
Alison L. Hannah United States	31	2.5k 0.9×	2.5k 1.1×	766 0.4×	763 0.7×	440 0.6×	122	4.9k
Walter E. Aulitzky Germany	34	1.1k 0.4×	1.4k 0.6×	1.1k 0.5×	385 0.4×	502 0.7×	121	3.6k
Pamela S. Becker United States	39	1.5k 0.5×	2.4k 1.0×	3.7k 1.7×	322 0.3×	797 1.1×	221	6.0k

Countries citing papers authored by Claire Mathiot

Since Specialization

Citations

This map shows the geographic impact of Claire Mathiot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Mathiot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Mathiot more than expected).

Fields of papers citing papers by Claire Mathiot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Mathiot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Mathiot. The network helps show where Claire Mathiot may publish in the future.

Co-authorship network of co-authors of Claire Mathiot

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Mathiot. A scholar is included among the top collaborators of Claire Mathiot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Mathiot. Claire Mathiot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bidard, François‐Clément, F. Huguet, Christophe Louvet, et al.. (2013). Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial. Annals of Oncology. 24(8). 2057–2061. 152 indexed citations

Avet‐Loiseau, Hervé, Florent Malard, L. Campion, et al.. (2010). Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?. Blood. 117(6). 2009–2011. 92 indexed citations

Avet‐Loiseau, Hervé, Xavier Leleu, Murielle Roussel, et al.. (2010). Bortezomib Plus Dexamethasone Induction Improves Outcome of Patients With t(4;14) Myeloma but Not Outcome of Patients With del(17p). Journal of Clinical Oncology. 28(30). 4630–4634. 298 indexed citations

Bidard, François‐Clément, Claire Mathiot, Armelle Degeorges, et al.. (2010). Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy. Annals of Oncology. 21(9). 1765–1771. 119 indexed citations

Harousseau, J. L., Hervé Avet‐Loiseau, J. Y. Mary, et al.. (2010). Bortezomib Plus Dexamethasone Versus Reduced-dose Bortezomib Plus Thalidomide-dexamethasone As Induction Prior To Autologous Transplantation in Newly Diagnosed Myeloma. 95. 451. 4 indexed citations

Hulin, Cyrille, Thierry Façon, Philippe Rodon, et al.. (2009). Efficacy of Melphalan and Prednisone Plus Thalidomide in Patients Older Than 75 Years With Newly Diagnosed Multiple Myeloma: IFM 01/01 Trial. Journal of Clinical Oncology. 27(22). 3664–3670. 266 indexed citations

Némati, Fariba, Claire Mathiot, Isabelle Grandjean, et al.. (2007). Imatinib mesylate reduces rituximab-induced tumor-growth inhibition in vivo on Epstein–Barr virus-associated human B-cell lymphoma. Anti-Cancer Drugs. 18(9). 1029–1037. 1 indexed citations

Brazier, Michel, Claire Mathiot, Jacques Jamart, et al.. (2004). Prognostic value of urinary pyridinium crosslinks and their derivatives in multiple myeloma. Annals of Hematology. 84(1). 19–24. 6 indexed citations

Cassard, Lydie, Joël F.G. Cohen-Solal, Annie Galinha, et al.. (2002). Modulation of tumor growth by inhibitory Fcγ receptor expressed by human melanoma cells. Journal of Clinical Investigation. 110(10). 1549–1557. 25 indexed citations

10.

Bauvois, Brigitte, J Dumont, Claire Mathiot, & J.P. Kolb. (2002). Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons. Leukemia. 16(5). 791–798. 88 indexed citations

11.

Goasguen, J, Marc Zandecki, Claire Mathiot, et al.. (1999). Mature plasma cells as indicator of better prognosis in multiple myeloma. New methodology for the assessment of plasma cell morphology. Leukemia Research. 23(12). 1133–1140. 39 indexed citations

12.

Tartour, Éric, Sylvain Latour, Claire Mathiot, et al.. (1995). Variable expression of CD3‐ζ chain in tumor‐infiltrating lymphocytes (TIL) derived from renal‐cell carcinoma: Relationship with til phenotype and function. International Journal of Cancer. 63(2). 205–212. 92 indexed citations

13.

Mathiot, Claire, A Portier, Maud Brandely, et al.. (1994). Increased expression of perforin and granzyme B genes in patients with metastatic melanoma treated with recombinant interleukin-2. Cancer Immunology Immunotherapy. 39(1). 53–58. 18 indexed citations

14.

Tartour, Éric, Thierry Dorval, Véronique Mosseri, et al.. (1994). Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients. British Journal of Cancer. 69(5). 911–913. 98 indexed citations

15.

Mathiot, Claire, Jean‐Luc Teillaud, Véronique Mosseri, et al.. (1993). Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myeloma. Journal of Clinical Immunology. 13(1). 41–48. 33 indexed citations

16.

Billard, Christian, Didier Ferbus, Roberto A. Díez, et al.. (1991). Correlation between the biological and therapeutic effects of interferon-alpha in low-grade nodular non-Hodgkin's lymphoma: Lack of in vivo down-regulation and reduced affinity of IFN-α receptors in unresponsive patients. Leukemia Research. 15(2-3). 121–128. 9 indexed citations

17.

Favrot, M, Jean Michon, D. Floret, et al.. (1990). Interleukin 2 Immunotherapy in Children with Neuroblastoma after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation. Pediatric Hematology and Oncology. 7(3). 275–284. 11 indexed citations

18.

Favrot, M, D. Floret, Jean Michon, et al.. (1989). A phase-II study of adoptive immunotherapy with continuous infusion of interleukin-2 in children with advanced neuroblastoma. A report on 11 cases. Cancer Treatment Reviews. 16. 129–142. 18 indexed citations

19.

Tolédano, Michel B., Claire Mathiot, Jean Michon, et al.. (1989). Interferon-γ (IFN-γ) and interleukin-2 in the generation of lymphokine-activated killer cell cytotoxicity — IFN-γ-induced suppressive activity. Cancer Immunology Immunotherapy. 30(1). 57–64. 15 indexed citations

20.

Mathiot, Claire, et al.. (1978). [Multifocal chloroma (granulocytic sarcoma), without marrow involvement. One case (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 7(28). 2461–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact